New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 25, 2014
10:00 EDTVIAB, VRTX, VMI, PBR, MEGGF, KRA, HOG, EVEP, DISCK, CTRP, COHOn The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: Coach (COH) downgraded at BofA/Merrill... Ctrip.com (CTRP) downgraded to Outperform from Strong Buy at Raymond James... Discovery Communications (DISCK) downgraded to Neutral from Buy at BTIG... EV Energy (EVEP) downgraded to Hold from Buy at Wunderlich... Harley-Davidson (HOG) downgraded at KeyBanc... Kraton Performance (KRA) downgraded to Neutral from Outperform at Credit Suisse... Meggitt (MEGGF) downgraded to Underweight from Neutral at JPMorgan... Petrobras (PBR) downgraded to Equal Weight from Overweight at Morgan Stanley... Valmont (VMI) downgraded to Neutral from Outperform at Wedbush... Vertex (VRTX) downgraded to Neutral from Buy at H.C. Wainwright... Viacom (VIAB) downgraded to Neutral from Buy at BTIG.
News For COH;CTRP;DISCK;EVEP;HOG;KRA;MEGGF;PBR;VMI;VRTX;VIAB From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | all recent news | >>
October 14, 2014
09:33 EDTHOGHarley-Davidson volatility elevated into Q3 and sales outlook
Subscribe for More Information
October 13, 2014
10:08 EDTVRTXOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
09:39 EDTPBRActive equity options trading on open
Subscribe for More Information
09:23 EDTVRTXVertex price target raised to $131 from $119 at RW Baird
Subscribe for More Information
05:35 EDTVRTXVertex upgraded to Overweight from Neutral at Piper Jaffray
Piper Jaffray upgraded Vertex Pharmaceuticals to Overweight citing likely approval of the company's Kalydeco plus lumacaftor combination next year. Piper expects Vertex's Cystic Fibrosis sales to grow to $3.1B in 2016 and raised its price target for shares to $125 from $87.50.
October 10, 2014
16:22 EDTCTRPPriceline raises stake in Ctrip.com to 6.88% from 5.84%
Subscribe for More Information
16:02 EDTPBRActionable Options for Friday, October, 10
Subscribe for More Information
12:11 EDTPBROptions with increasing implied volatility
Subscribe for More Information
09:38 EDTPBRActive equity options trading on open
Subscribe for More Information
08:24 EDTVRTXVertex price target raised to $117 from $109 at Maxim
Maxim raised its price target for Vertex shares to $117 after the company gave an update at the Cystic Fibrosis Conference. The form keeps a Buy rating on the stock.
October 9, 2014
16:00 EDTPBROptions Update; October 9, 2014
Subscribe for More Information
11:00 EDTPBROptions with increasing implied volatility
Options with increasing implied volatility: ARWR PBR EXXI PWE GST GLNG WTW AFSI ETE VALE
09:41 EDTCOHBofA/Merrill retail analysts hold an analyst/industry conference call
Subscribe for More Information
09:38 EDTPBRActive equity options trading on open
Subscribe for More Information
09:33 EDTVRTXVertex says VX-661 Phase 2 study fully enrolled
Subscribe for More Information
07:22 EDTVRTXCystic Fibrosis Foundation to hold a conference
Subscribe for More Information
October 8, 2014
16:01 EDTPBROptions Update; October 8, 2014
iPath S&P 500 VIX Short-Term Futures down 2.73 to 29.51. Option volume leaders: AAPL TSLA TWTR AMZN FB NFLX PBR AA CLF GILD according to Track Data.
14:26 EDTPBRPetrobras volatility elevated on crude trends lower
Subscribe for More Information
09:38 EDTPBRActive equity options trading on open
Subscribe for More Information
07:25 EDTVIABViacom threatens to remove channels in Canada over unbundling, Globe & Mail says
Viacom (VIA, VIAB) is threatening to remove its stations off Canadian cable systems and onto an online streaming service if the Canadian Radio-television and Telecommunications Commission forces carriers to offer channels on a “pick-and-pay,” or unbundled, basis, reported The Globe and Mail. Reference Link
1 | 2 | 3 | 4 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use